Position in INVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,386,676
+$117,132 QoQ
Shares Held
59,514
-6.3% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,124,718 across 78 Biotechnology names. INVA ranks #28 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in INVA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,386,676 | 59,514 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,269,544 | 63,509 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $941,298 | 51,578 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $960,382 | 47,804 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,154,862 | 63,699 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,210,925 | 69,794 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,135,447 | 58,801 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $964,336 | 58,801 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $755,294 | 49,560 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $758,980 | 47,318 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $673,375 | 51,838 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $675,110 | 53,033 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $672,300 | 59,760 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $791,820 | 59,760 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $798,814 | 68,804 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $1,029,981 | 53,229 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $918,200 | 53,229 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $889,456 | 53,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $713,800 | 53,229 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $659,819 | 55,215 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $771,661 | 62,281 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $787,334 | 75,343 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $1,154,761 | 82,601 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,049,039 | 89,204 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||